ClinicalTrials.Veeva

Menu

Improving Human Ovarian Transplantation

H

Hadassah Medical Center

Status and phase

Unknown
Early Phase 1

Conditions

Fertility Preservation

Treatments

Procedure: ovarian transplantation

Study type

Interventional

Funder types

Other

Identifiers

NCT00827476
0530-08-HMO- CTIL

Details and patient eligibility

About

we will perform xenotransplantation and in vitro culture of ovarian tissue from patients undergoing ovarian cortex cryopreservation.

Full description

Ovarian tissue is removed by laparoscopy and only in patients facing premature ovarian failure due to chemotherapy.Tissue for research will consist either of a small portion (<10%) of the cortex for preservation for young women. another source of ovarian tissue for research will be obtained following consent from family of patients who have died of the disease and have previously frozen ovarian tissue.

Enrollment

100 estimated patients

Sex

Female

Ages

5 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • tissue previously obtained

Exclusion criteria

  • no tissue available or no consent

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

100 participants in 1 patient group

ovarian transplantation
Experimental group
Description:
tissue will be used for xenotransplantation or in vitro culture
Treatment:
Procedure: ovarian transplantation

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems